See every side of every news story
Published loading...Updated

New combined therapy helps extend lives of men with prostate cancer

Summary by Ground News
A combination of androgen deprivation therapy and pelvic lymph node radiation kept nearly 90% of clinical trial patients at bay for five years. The findings were published in the peer-reviewed journal The Lancet. Prostate cancer is the most common non-skin cancer in the U.S., affecting 1 in every 6 to 7 men.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Thursday, May 26, 2022.
Sources are mostly out of (0)

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.